Menopause Discrimination Claims: Understanding Employer Legal Risk

Menopause is not a protected characteristic in UK law. Yet employers are already losing tribunal cases and facing discrimination findings where routine processes collide with menopausal symptoms that meet Equality Act thresholds.

That tension is now hard to ignore. The government rejected the Women and Equalities Committee’s call to make menopause a specific protected characteristic, citing concerns about unintended consequences. At the same time, the Equality and Human Rights Commission (EHRC) has issued detailed menopause guidance and tribunals are upholding claims under existing grounds: age, sex and disability.

For HR leaders, the message is uncomfortable but clear: legal risk is not waiting for new rights. It is embedded in how absence, performance, recruitment and health and safety are currently run.

This distinction matters.

Up to 84% of women report negative impacts on their work due to menopause and a third consider leaving employment. That is a sizeable cohort interacting daily with systems designed without menopause in mind. When those systems apply rigid rules to symptoms that meet the Equality Act disability definition – a long‑term, substantial impact on normal day‑to‑day activities – the legal hooks are already in place.

The EHRC is explicit: where menopause symptoms meet that threshold, employers must avoid direct and indirect discrimination, discrimination arising from disability, and must make reasonable adjustments. Women experiencing menopause may also be protected from harassment and victimisation related to age and sex. Gender reassignment discrimination can be engaged where hormone treatment triggers menopausal symptoms.

Tribunals are applying this framework. In Ms Merchant v BT, the tribunal upheld a sex discrimination claim after performance concerns were pursued and dismissal followed without the manager properly engaging with medical evidence about menopause. In Maria Rooney v Leicester City Council, the tribunal held that menopause symptoms could amount to a disability and that unfair treatment over menopause‑linked absences contributed to resignation, triggering the duty to make adjustments.

Protection bites early. As employment law commentary notes, discrimination rights under age, sex and disability apply from recruitment onwards and from day one of employment, unlike unfair dismissal. A hiring manager’s assumptions about a mid‑life candidate’s “reliability” or “energy” if she discloses menopausal symptoms are therefore not just culturally problematic; they are legally actionable.

Health and safety law adds a further layer. Employers must conduct workplace risk assessments; EHRC guidance is clear this includes considering risks linked to menopause and taking appropriate steps. Ignoring temperature, ventilation, uniform requirements or access to toilets and drinking water for symptomatic workers is not just poor practice. It may be a breach.

The complication is that most of these duties are triggered indirectly, via systems that were never designed with menopause in mind.

Where HR systems go wrong – and how to de‑risk them

Legal exposure is now arising not from isolated “bad apple” managers, but from well‑intentioned processes that treat menopause as irrelevant. A diagnostic look at four pressure points shows why.

First, absence management. Many organisations operate trigger‑based policies where a set number of absences automatically prompts formal action. If those absences stem from severe hot flushes, insomnia or cognitive symptoms that meet the disability threshold, penalising the employee without considering reasonable adjustments can amount to discrimination on disability, sex or age grounds. The Rooney case illustrates how quickly this can escalate when absence is treated purely as a conduct issue.

A practical shift is to build an explicit “reasonable adjustment” checkpoint into absence procedures. Before formal action is authorised, managers should be required to review whether any underlying health condition – including menopause – could be in play, and whether adjustments such as flexible hours, temporary homeworking or changes to duties are feasible. Digital tools can support this. For example, behavioural‑science‑led platforms like Leafyard use interactive assessments and structured journalling to help employees track symptoms and stress patterns over time, generating data that can underpin informed, timely adjustment discussions rather than last‑minute crisis responses.

Second, performance and capability. The Merchant decision shows the risk of pushing ahead with performance management while sidelining medical evidence. Where concentration, memory or fatigue issues are linked to menopause and meet the disability test, proceeding straight to capability hearings without exploring adjustments – for example, altered deadlines, task reprioritisation or environmental changes – invites claims of discrimination arising from disability.

Here, mental fitness framing is useful. Treating menopause‑related cognitive changes as a trainable mental fitness challenge, rather than a fixed deficit, opens up more constructive options. Microlearning and guided video coaching on sleep, resilience and stress management can form part of a preventative package, helping employees build coping strategies before performance deteriorates. Leafyard’s multi‑month journeys and five‑day experiments are examples of how HR can embed habit‑building into daily work, reducing the likelihood that symptoms ever cross the threshold into formal capability territory.

Third, health and safety risk assessments. Irish litigation in Rotunda Hospital v McNally, where failure to consider reasonable accommodation for menopause‑related issues led to a finding of direct discrimination, underlines that this is not a theoretical risk. UK employers face similar duties: to identify hazards, assess risks and implement controls. Excluding menopause from generic assessments – particularly in roles involving PPE, hot environments or rigid scheduling – is a governance gap.

Integrating menopause into standard risk templates is a relatively low‑cost fix. That can mean specific prompts on temperature control, access to rest areas, uniform flexibility and break patterns, backed by clear signposting to support. Hormonal health tools, such as Leafyard’s Hormonal Health Lab, can also strengthen the evidence base by giving employees accessible ways to log symptoms, visualise trends and share concise summaries with occupational health or GPs. Better data makes it easier to justify proportionate adjustments and demonstrate that risks have been actively considered.

Fourth, recruitment and progression. Because most people experiencing menopause are women aged 45–55, patterns of unfavourable treatment in this cohort can readily be framed as both sex and age discrimination. Being passed over for promotion following menopause‑related sickness, disparaging comments about “women of a certain age”, or subtle steering away from client‑facing roles can all cross legal lines.

HR’s leverage here lies in analytics and training. Behavioural analytics that anonymise and segment data by age and gender can highlight where mid‑life women are disproportionately exiting, stalled in progression or subject to capability routes. Platforms that translate these patterns into board‑ready reports and pounds‑and‑pence ROI, as Leafyard does, help connect menopause‑sensitive practice directly to retention, absence and performance metrics. Leafyard’s case studies show how this kind of data‑driven approach can underpin measurable improvements in engagement and mental health‑related absence. This is not simply a wellbeing narrative; it is a risk and value narrative the board can recognise.

Finally, support pathways themselves can create or mitigate risk. Traditional EAPs often function as reactive hotlines with low utilisation. When menopausal symptoms are left to worsen until they drive grievances or claims, everyone loses. A preventative, mental‑fitness‑oriented modern EAP – with 24/7 intelligent triage, NCPS‑accredited counsellors and same‑day appointments – enables earlier disclosure and intervention. Where traditional models fall short, Leafyard’s always‑on, digital‑first design gives HR more room to explore adjustments, resolve issues informally and document a reasonable, evidence‑based response.

For HR Directors, the strategic task is now to treat menopause as a live compliance lens on existing systems, not an optional add‑on pending legislative reform. That means auditing absence triggers, performance and capability pathways, recruitment and promotion decisions, and health and safety assessments specifically against Equality Act duties and EHRC guidance, and equipping managers with simple, legally grounded scripts and routes to support. Leafyard’s emphasis on measurable outcomes and behaviour change offers one model of how wellbeing infrastructure can be aligned with that compliance agenda.

When menopause is built into the way decisions are made – backed by intelligent wellbeing infrastructure and hard data – the legal risk recedes and retention improves. The next move is yours.